GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
2.610
-0.300 (-10.31%)
At close: Nov 20, 2024, 4:00 PM
2.590
-0.020 (-0.77%)
Pre-market: Nov 21, 2024, 5:07 AM EST
GeoVax Labs Revenue
GeoVax Labs had revenue of $2.79M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $3.09M.
Revenue (ttm)
$3.09M
Revenue Growth
n/a
P/S Ratio
2.76
Revenue / Employee
$181,774
Employees
17
Market Cap
24.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 81.53K | -303.98K | -78.85% |
| Dec 31, 2021 | 385.50K | -1.44M | -78.86% |
| Dec 31, 2020 | 1.82M | 647.76K | 55.09% |
| Dec 31, 2019 | 1.18M | 212.69K | 22.08% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Neuronetics | 72.71M |
| Equillium | 45.91M |
| DarioHealth | 23.05M |
| Lipocine | 7.92M |
| NEXGEL | 6.73M |
| BioXcel Therapeutics | 2.28M |
| CytoMed Therapeutics | 330.25K |
GOVX News
- 8 days ago - GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 15 days ago - GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024 - GlobeNewsWire
- 7 weeks ago - GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
- 2 months ago - GeoVax to Participate in Upcoming Investor Conferences in September - GlobeNewsWire
- 3 months ago - GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market - GlobeNewsWire
- 3 months ago - GeoVax's stock slides 20% after company raises $8.5 million in stock sale - Market Watch
- 3 months ago - GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market - GlobeNewsWire